Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jan-Paul Esser"'
Autor:
Asbjørn M. Scholtens, Jan Paul Esser, N. L. van der Sluis, Hein J. Verberne, G. K. Lammers, A. M. van den Berk, Marnix G.E.H. Lam, J. M. H. De Klerk
Publikováno v:
European journal of nuclear medicine and molecular imaging, 47(11), 2698-2702. Springer Verlag
Introduction: Adequate suppression of physiologic myocardial glucose uptake is important to ensure the interpretability and diagnostic reliability of [18F]fluorodeoxyglucose (FDG) PET/CT studies performed in the context of cardiac inflammation and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3877b12e01080f2e6a7de568dcb7af86
https://doi.org/10.1007/s00259-020-04713-1
https://doi.org/10.1007/s00259-020-04713-1
Autor:
Pieternel C. M. Pasker, Gauke K. Lammers, John M. H. de Klerk, Marina E. Sanson-van Praag, Jan Paul Esser
Publikováno v:
Advances in Molecular Imaging. :27-34
Introduction: The aim of the study was to assess the role of I-124 PET/CT in the prediction of uptake of a therapeutic dosage I-131 during follow-up of patients with differentiated thyroid cancer (DTC). Methods: The results of 34 I-124 PET/CT scans p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdecf191d29e6a1dc89f8e056f45a1ab
https://doi.org/10.4236/ami.2014.43004
https://doi.org/10.4236/ami.2014.43004
Autor:
Henk J. Baarslag, Adriaan J. van Overbeeke, Jan Paul Esser, Marie J. de Haas, Lioe-Fee de Geus-Oei, John M. H. de Klerk, B.F. Bulten, C. J. Rodenburg, Haiko J. Bloemendal
Publikováno v:
Advances in Molecular Imaging. :35-41
Objectives: In grade III-IV breast cancer, dissemination of disease needs to be assessed. Until now this was done by conventional imaging (liver ultrasonography, chest X-ray and bone scintigraphy), but evidence favoring the use of FDG-PET/CT is accum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8f70048cf4fdb580ea07f87ceece4de
https://doi.org/10.4236/ami.2014.43005
https://doi.org/10.4236/ami.2014.43005
Autor:
P. P. M. Kooij, Jaap J.M. Teunissen, A. van Gameren, Willem H. Bakker, Dirk Jan Kwekkeboom, Eric P. Krenning, Jan-Paul Esser
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 33:1346-1351
Patients with somatostatin receptor subtype 2-positive metastasised neuroendocrine tumours can be treated with [(177)Lu-DOTA(0),Tyr(3)]octreotate. Some use octreotide as the peptide for peptide receptor radionuclide therapy (PRRT). We compared in sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4188899295935eb0e90b3e6132d1896
https://doi.org/10.1007/s00259-006-0172-9
https://doi.org/10.1007/s00259-006-0172-9
Autor:
Jaap J M, Teunissen, Dik J, Kwekkeboom, Marion, de Jong, Jan-Paul, Esser, Roelf, Valkema, Eric P, Krenning
Publikováno v:
Best practiceresearch. Clinical gastroenterology. 19(4)
Peptide receptor radionuclide therapy is a new treatment modality for patients with inoperable or metastasised neuroendocrine gastroenteropancreatic tumours. After the successful implementation of somatostatin receptor scintigraphy in daily clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87952aee14d59cf556d7e073e7e2bfe3
https://pubmed.ncbi.nlm.nih.gov/16183530
https://pubmed.ncbi.nlm.nih.gov/16183530
Publikováno v:
Clinical Nuclear Medicine, 29(12), 793-794. Lippincott Williams & Wilkins
An unusual phenomenon during lung scintigraphy is presented. Besides visualization of the lungs, accumulation of Tc-99m macroaggregated albumin (MAA) was seen in a small part of the liver and in and around several thoracic vertebrae. Contrast-enhance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9a41fab0f7d82dce327df9f95da8106
https://pubmed.ncbi.nlm.nih.gov/15545880
https://pubmed.ncbi.nlm.nih.gov/15545880
Publikováno v:
Clinical Nuclear Medicine, 28(10), 845-846. Lippincott Williams & Wilkins
A 49-year-old man with multiple myeloma underwent whole-body bone scanning for evaluation of bone pain. Blood tests indicated elevated serum concentrations of calcium, 17.3 mg/dL; phosphate, 5.2 mg/dL; and creatinine, 5.5 mg/dL. The bone scan reveale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065162173ba4597458039d2a0ce11339
https://doi.org/10.1097/01.rlu.0000090934.83420.72
https://doi.org/10.1097/01.rlu.0000090934.83420.72
Publikováno v:
Clinical Nuclear Medicine; Oct2003, Vol. 28 Issue 10, p845, 2p